Entrada Therapeutics
TRDA
#9077
Rank
HK$1.33 B
Marketcap
HK$34.10
Share price
-6.25%
Change (1 day)
-56.66%
Change (1 year)

EPS for Entrada Therapeutics (TRDA)

EPS in 2026 (TTM): -HK$30.06

According to Entrada Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$30.10. In 2025 the company made an earnings per share (EPS) of -HK$27.12 a decrease over its 2024 EPS that were of HK$15.60.

EPS history for Entrada Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$30.0610.82%
2025-HK$27.12-273.87%
2024HK$15.60
2022-HK$23.6731.74%
2021-HK$17.97